| Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells B Boyerinas, C Jochems, M Fantini, CR Heery, JL Gulley, KY Tsang, ... Cancer immunology research 3 (10), 1148-1157, 2015 | 581 | 2015 |
| In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: Perspectives on cancer treatment M Fantini, M Benvenuto, L Masuelli, GV Frajese, I Tresoldi, A Modesti, ... International journal of molecular sciences 16 (5), 9236-9282, 2015 | 380 | 2015 |
| Dietary flavonoids: molecular mechanisms of action as anti-inflammatory agents L Marzocchella, M Fantini, M Benvenuto, L Masuelli, I Tresoldi, A Modesti, ... Recent patents on inflammation & allergy drug discovery 5 (3), 200-220, 2011 | 189 | 2011 |
| An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele C Jochems, JW Hodge, M Fantini, R Fujii, YM Morillon II, JW Greiner, ... Oncotarget 7 (52), 86359-86373, 2016 | 174 | 2016 |
| Sarcopenia and fragility fractures: molecular and clinical evidence of the bone-muscle interaction U Tarantino, E Piccirilli, M Fantini, J Baldi, E Gasbarra, R Bei J Bone Joint Surg Am 97 (5), 429-437, 2015 | 159 | 2015 |
| In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors. M Benvenuto, L Masuelli, E De Smaele, M Fantini, R Mattera, D Cucchi, ... Oncotarget 7 (8), 9250-9270, 2016 | 123 | 2016 |
| The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells. C Jochems, M Fantini, RI Fernando, AR Kwilas, RN Donahue, LM Lepone, ... Oncotarget, 2016 | 119 | 2016 |
| Resveratrol potentiates the in vitro and in vivo anti-tumoral effects of curcumin in head and neck carcinomas L Masuelli, E Di Stefano, M Fantini, R Mattera, M Benvenuto, ... Oncotarget 5 (21), 10745-62, 2014 | 109 | 2014 |
| Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody RN Donahue, LM Lepone, I Grenga, C Jochems, M Fantini, RA Madan, ... Journal for immunotherapy of cancer 5 (1), 1-16, 2017 | 91 | 2017 |
| Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice. L Masuelli, M Benvenuto, M Fantini, L Marzocchella, P Sacchetti, ... Journal of biological regulators and homeostatic agents 27 (1), 105-119, 2013 | 78 | 2013 |
| Curcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant … L Masuelli, M Benvenuto, E Di Stefano, R Mattera, M Fantini, G De Feudis, ... Oncotarget 8 (21), 34405, 2017 | 77 | 2017 |
| Biological effects of in vitro THz radiation exposure in human foetal fibroblasts A De Amicis, S De Sanctis, S Di Cristofaro, V Franchini, F Lista, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 793, 150-160, 2015 | 74 | 2015 |
| Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and … L Masuelli, F Pantanella, G La Regina, M Benvenuto, M Fantini, R Mattera, ... Tumor Biology 37 (3), 3705-3717, 2016 | 72 | 2016 |
| Carcinoembryonic antigen (CEA)-based cancer vaccines: recent patents and antitumor effects from experimental models to clinical trials M Turriziani, M Fantini, M Benvenuto, V Izzi, L Masuelli, P Sacchetti, ... Recent patents on anti-cancer drug discovery 7 (3), 265-296, 2012 | 68 | 2012 |
| Tendon’s ultrastructure I Tresoldi, F Oliva, M Benvenuto, M Fantini, L Masuelli, R Bei, A Modesti Muscles, ligaments and tendons journal 3 (1), 2, 2013 | 67 | 2013 |
| Co-circulation of dengue and chikungunya viruses, Al Hudaydah, Yemen, 2012 G Rezza, G El-Sawaf, G Faggioni, F Vescio, R Al Ameri, R De Santis, ... Emerging infectious diseases 20 (8), 1351, 2014 | 66 | 2014 |
| Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types. GSR Hicks KC, Fantini M, Donahue RN, Schwab A, Knudson KM, Tritsch SR ... Oncoimmunology 7 (11), e1466018, 2018 | 63 | 2018 |
| ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti‐PD‐L1 antibody C Jochems, JW Hodge, M Fantini, KY Tsang, AJ Vandeveer, JL Gulley, ... International journal of cancer 141 (3), 583-593, 2017 | 49 | 2017 |
| Resveratrol and diallyl disulfide enhance curcumin-induced sarcoma cell apoptosis L Masuelli, L Marzocchella, C Focaccetti, I Tresoldi, C Palumbo, V Izzi, ... Front Biosci 17 (1), 498-508, 2012 | 49 | 2012 |
| Potassium increases the antitumor effects of ascorbic acid in breast cancer cell lines in vitro GV Frajese, M Benvenuto, M Fantini, E Ambrosin, P Sacchetti, L Masuelli, ... Oncology Letters 11 (6), 4224-4234, 2016 | 42 | 2016 |
Roberto BeiFull Professor of General Pathology在 med.uniroma2.it 的电子邮件经过验证
